TownSquare Capital’s GSK GSK Stock Holding History

TownSquare Capital’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-102,180	Closed	-$3.96M	–	1022
2025 Q1	$3.96M	Buy	102,180 +16,165	+19%	+$592K	0.04%	381
2024 Q4	$2.91M	Sell	86,015 -12,352	-13%	-$445K	0.03%	463
2024 Q3	$4.02M	Buy	98,367 +7,151	+8%	+$293K	0.05%	350
2024 Q2	$3.51M	Buy	91,216 +15,379	+20%	+$647K	0.05%	346
2024 Q1	$3.25M	Buy	+75,837	New	+$3.13M	0.05%	341

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return

TownSquare Capital's GSK Position: Q2 2025 in Review

TownSquare Capital sold out of GSK (GSK) in Q2 2025, closing a stake of 102,180 shares — an estimated $3.96M sold.

TownSquare Capital first reported a position in GSK in Q1 2024 and held it in 5 quarters. The position peaked at $4.02M in Q3 2024. 890 funds tracked by Wall St. Rank hold GSK as of Q2 2025.

TownSquare Capital reported no remaining GSK position as of Q2 2025 after selling out during the quarter.
TownSquare Capital sold 102,180 GSK shares in Q2 2025, an estimated $3.96M.
TownSquare Capital first reported a position in GSK in Q1 2024 and held it in 5 quarters.
TownSquare Capital's GSK position peaked at $4.02M in Q3 2024.
890 funds tracked by Wall St. Rank held GSK as of Q2 2025.

Based on TownSquare Capital's 13F filing for Q2 2025, filed 13 Aug 2025.